Researchers at the Massachusetts Institute of Technology (MIT) have unveil groundbreaking cell-wearable devices that can transform the treatment of neurological disorders, including multiple sclerosis (MS).
These micro-scale devices, which wrap around individual neurons, mimic the function of natural myelin and restore the electrical signalling disrupted by neurodegenerative diseases.
Battery-free and activate by light, the devices offer a new way to monitor and potentially modulate neuron activity within the body.
According to the report by Neuro Science News, these tiny devices are craft from a soft polymer that rolls and adheres to axons and dendrites when expose to specific light wavelengths.
This unique action allows the device to envelop neuronal structures without damaging delicate cellular components.
As per Deblina Sarkar, head of MIT’s Nano-Cybernetic Biotrek Lab, this design is a step towards creating symbiotic neural interfaces that work at a cellular level.
Deblina Sarkar said :
By wrapping around axons, the neural “wiring” responsible for transmitting electrical impulses, the device can act like synthetic myelin, potentially restoring functions in damaged neurons.
To create these wearables, researchers use azobenzene, a light-sensitive material.
When expose to specific light wavelengths, azobenzene films form microtubes that snugly wrap around neuronal structures.
Lead author Marta J. I. Airaghi Leccardi, now a Novartis Innovation Fellow, highlights that the team develop a fabrication technique scalable enough to produce thousands of these microdevices without a semiconductor cleanroom.
Marta J. I. Airaghi Leccardi said :
MIT researchers are optimistic about the potential to integrate these devices with advance sensors, which could open new pathways for non-invasive brain treatments.
The devices may one day help clinicians and researchers monitor electrical, optical, and even thermal signals from neurons, offering a deeper understanding of brain function.
Flavia Vitale, associate professor at the University of Pennsylvania, call as the research “an exciting foundation” for future in vivo applications, where the devices might aid in treating neurodegenerative diseases more effectively.